1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Cutaneous Squamous Cell Carcinoma: new trials by email Literature Review of Cutaneous Squamous Cell Carcinoma trials Research Report on Cutaneous Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma Cemiplimab, Placebo - Cutaneous Squamous Cell Carcinoma | Phase 3 | Active not recruiting | Regeneron Pharmaceuticals | 415 | 2019-06-04 | 2026-03-27 |
cemiplimab (1)
Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Greece (1) · Ireland (1) · Italy (1) · Japan (1) · New Zealand (1) · Poland (1) · Russia (1) · Spain (1) · United Kingdom (1)
2019 (1)